|
KMID : 1141720220100010037
|
|
폐쇄성폐질환
2022 Volume.10 No. 1 p.37 ~ p.41
|
|
|
|
|
Sin Soo-Im
|
|
|
Abstract
|
|
|
|
Digital therapeutics (DTx) provide evidence-based medical interventions to patients through software technology. Digital inhalers detect the patient’s history of inhaler usage through the sensor attached to the inhaler and afterward save, transmit it to the application which provides alarm, feedback, and education to the patients. Dashboard allows patients to review the saved data and share them with doctors. The main goal of digital inhaler is to improve adherence of inhaler usage. Several studies proved that digital inhaler can improve inhaler adherence, disease control and technique for inhaler usage in asthma or COPD patients. Furthermore, recently one study proposed prediction model of asthma exacerbation based on the combination of patient symptom and inhaler usage history. Digital inhaler is expected to enable provide personalized medicine as well as solving low-adherence problem. In Korea, development and commercialization of digital inhaler would be facilitated based on well formulated approval policies and insurance policies on DTx.
|
|
|
KEYWORD
|
|
|
Digital therapeutics, Technology, Pulmonary disease, Chronic obstructive, Asthma, Administration
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|